Screening for type 1 diabetes risk in relatives in Quebec
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study is testing a program to screen adults who have a close relative with type 1 diabetes (T1D) for early signs of the condition. The goal is to see if screening can identify people at risk before symptoms start, so they can get follow-up care if needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older and live in Quebec.
- You have a parent, sibling, or child with type 1 diabetes.
- You are willing to follow up with care if screening shows you are at risk.
- You do not already have type 1 diabetes.
- You are not pregnant or trying to become pregnant.
- You are not currently using certain medications like glucocorticoids or other immune-suppressing drugs.
- You have not had recent treatments like monoclonal antibodies or plasma exchange.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people ages 1 to 45 who have a close family member or friend with type 1 diabetes. It aims to detect type 1 diabetes early by screening people who may be at higher risk.
This study tests a program to screen children for type 1 diabetes during regular checkups. The goal is to see if adding this screening to routine blood tests helps find early signs of diabetes, so families can get earlier care and support.
This study screens high-risk children for early signs of type 1 diabetes by testing relatives who already have the condition. It aims to catch diabetes early so treatment can start sooner.
This study screens brothers, sisters, and children of people with type 1 diabetes to find early signs of the disease before symptoms appear. The goal is to catch it early and offer monitoring or future prevention options.
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
This study checks whether health databases correctly identify people with type 1 diabetes, type 2 diabetes, or LADA. If you live in Quebec and were diagnosed between 1997 and 2024, your medical records could help improve how diabetes is tracked.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.